ELMSFORD, N.Y., April 27, 2015 /PRNewswire/ -- BioScrip, Inc.
(NASDAQ: BIOS) ("BioScrip"), a leading national provider of
infusion and home care management solutions, today announced that
Jeffrey M. Kreger will join the
Company as Senior Vice President, Chief Financial Officer and
Treasurer, effective April 27,
2015.
Kreger joins BioScrip with over 25 years of experience in
financial and executive leadership roles. He most recently served
as Senior Vice President of Finance with LHC Group Inc., a
NASDAQ-listed post-acute healthcare services company. In that role,
he led a staff of over 300 personnel spanning all aspects of
finance, accounting, treasury and information technology functions.
He was instrumental in the development and execution of LHC's
five-year strategic plan, led all corporate financing activities,
and was actively involved in corporate development, overseeing the
valuation, purchase, and integration of four large acquisitions in
less than 19 months.
"Jeff is a highly experienced and talented CFO with an
outstanding background and leadership capabilities," said
Richard M. Smith, Chief Executive
Officer and President of BioScrip. "His track record demonstrates
an ability to build value and drive growth for healthcare services
companies, and we look forward to working with Jeff as we continue
to build upon our leading position in infusion while expanding into
post-acute care services."
"I am very excited to join BioScrip at this point in the
Company's development," said Jeffrey
Kreger. "Our focus will continue to be to provide
outstanding health care services at the most appropriate
point-of-care for patients, while offering cost-effective solutions
for payors and customers, and enhancing BioScrip's profitability. I
believe there is a tremendous opportunity at BioScrip to continue
to build its infusion platform and I'm excited to be a part of the
team."
Prior to joining LHC Group in 2013, Kreger served as Senior Vice
President and Corporate Controller at Sun Healthcare Group, a
NASDAQ-listed post-acute care company with over 200 health care
centers across 46 states and annual revenues in 2011 exceeding
$1.9 billion. He previously held
senior finance roles at NYSE- and NASDAQ- listed companies
including Consolidated Graphics and Philip Services Corporation. He
began his career with an eight-year term in the audit practice of
Ernst & Young. Kreger holds an MBA from The University of Houston, and a BBA in Accounting from
the University of Texas at Austin. He
is a member of the Society of Louisiana Certified Public
Accountants.
Caldwell Partners acted as advisor for this placement.
About BioScrip
BioScrip, Inc. is a leading national
provider of infusion and home care management solutions.
BioScrip partners with physicians, hospital systems, skilled
nursing facilities, healthcare payors, and pharmaceutical
manufacturers to provide patients access to post-acute care
services. BioScrip operates with a commitment to bring
customer-focused pharmacy and related healthcare infusion therapy
services into the home or alternate-site setting. By
collaborating with the full spectrum of healthcare professionals
and the patient, BioScrip provides cost-effective care that is
driven by clinical excellence, customer service, and values that
promote positive outcomes and an enhanced quality of life for those
it serves. BioScrip provides its infusion and home care
services from over 70 locations across 28 states.
Forward-Looking Statements – Safe Harbor
This press release includes statements that may constitute
"forward-looking statements," including projections of certain
measures of the Company's results of operations, projections of
certain charges and expenses, and other statements regarding the
Company's goals, regulatory approvals and strategy. These
statements are made pursuant to the safe harbor provisions of the
Private Securities Litigation Reform Act of 1995. You can identify
these statements by the fact that they do not relate strictly to
historical or current facts. In some cases, forward-looking
statements can be identified by words such as "may," "should,"
"could," "anticipate," "estimate," "expect," "project," "outlook,"
"aim," "intend," "plan," "believe," "predict," "potential,"
"continue" or comparable terms. Because such statements inherently
involve risks and uncertainties, actual future results may differ
materially from those expressed or implied by such forward-looking
statements. Investors are cautioned that any such forward-looking
statements are not guarantees of future performance and involve
risks and uncertainties, and that actual results may differ
materially from those in the forward-looking statements as a result
of various factors. Important factors that could cause or
contribute to such differences include but are not limited to risks
associated with: the Company's ability to grow its Infusion
Services segment organically or through acquisitions and obtain
financing in connection therewith; its ability to reduce operating
costs while sustaining growth; reductions in federal, state and
commercial reimbursement for the Company's products and services;
increased government regulation related to the health care and
insurance industries; as well as the risks described in the
Company's periodic filings with the Securities and Exchange
Commission, including the Company's annual report on Form 10-K for
the year ended December 31, 2014. The
Company does not undertake any duty to update these forward-looking
statements after the date hereof, even though the Company's
situation may change in the future. All of the forward-looking
statements herein are qualified by these cautionary
statements.
Logo -
http://photos.prnewswire.com/prnh/20130117/NY44138LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/bioscrip-appoints-veteran-finance-executive-jeffrey-m-kreger-as-chief-financial-officer-300072246.html
SOURCE BioScrip, Inc.